Maninder Hora - Net Worth and Insider Trading
Maninder Hora Net Worth
The estimated net worth of Maninder Hora is at least $117,421 dollars as of 2024-09-20. Maninder Hora is the SVP Pharma Dev & Mfg Ops of Nektar Therapeutics and owns about 94,694 shares of Nektar Therapeutics (NKTR) stock worth over $117,421. Details can be seen in Maninder Hora's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Maninder Hora has not made any transactions after 2019-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Maninder Hora
Maninder Hora Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Maninder Hora owns 2 companies in total, including Nektar Therapeutics (NKTR) , and PDL BioPharma Inc (PDLI) .
Click here to see the complete history of Maninder Hora’s form 4 insider trades.
Insider Ownership Summary of Maninder Hora
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2019-05-16 | SVP Pharma Dev and Mfg |
| PDLI | PDL BioPharma Inc | 2008-08-13 | VP of Product Operations |
Maninder Hora Latest Holdings Summary
Maninder Hora currently owns a total of 1 stock. Maninder Hora owns 94,694 shares of Nektar Therapeutics (NKTR) as of May 16, 2019, with a value of $117,421.
Latest Holdings of Maninder Hora
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2019-05-16 | 94,694 | 1.24 | 117,421 |
Holding Weightings of Maninder Hora
Maninder Hora Form 4 Trading Tracker
According to the SEC Form 4 filings, Maninder Hora has made a total of 0 transactions in Nektar Therapeutics (NKTR) over the past 5 years. The most-recent trade in Nektar Therapeutics is the sale of 2,449 shares on May 16, 2019, which brought Maninder Hora around $76,825.
Insider Trading History of Maninder Hora
- 1
Maninder Hora Trading Performance
Maninder Hora Ownership Network
Maninder Hora Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Maninder Hora is the SVP Pharma Dev and Mfg of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Maninder Hora made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 111,800 shares made by Howard W Robin , a net sale of 52,375 shares made by Jonathan Zalevsky , and a net sale of 41,460 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 27,398 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 27,398 shares. During the past 18 months, 289,853 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 289,853 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Maninder Hora Mailing Address
Above is the net worth, insider trading, and ownership report for Maninder Hora. You might contact Maninder Hora via mailing address: Pdl Biopharma, Inc., 1400 Seaport Boulevard, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
